Author: Ahmedin Jemal
Publisher:
ISBN: 9781604432282
Category : Cancer
Languages : en
Pages : 0
Book Description
This atlas illustrates the latest available data on the cancer epidemic, showing causes, stages of development, and prevalence rates of different types of cancers by gender, income group, and region. It also examines the cost of the disease, both in terms of health care and commercial interests, and the steps being taken to curb the epidemic, from research and screening to cancer management programs and health education.
The Cancer Atlas
Author: Ahmedin Jemal
Publisher:
ISBN: 9781604432282
Category : Cancer
Languages : en
Pages : 0
Book Description
This atlas illustrates the latest available data on the cancer epidemic, showing causes, stages of development, and prevalence rates of different types of cancers by gender, income group, and region. It also examines the cost of the disease, both in terms of health care and commercial interests, and the steps being taken to curb the epidemic, from research and screening to cancer management programs and health education.
Publisher:
ISBN: 9781604432282
Category : Cancer
Languages : en
Pages : 0
Book Description
This atlas illustrates the latest available data on the cancer epidemic, showing causes, stages of development, and prevalence rates of different types of cancers by gender, income group, and region. It also examines the cost of the disease, both in terms of health care and commercial interests, and the steps being taken to curb the epidemic, from research and screening to cancer management programs and health education.
Ovarian Cancers
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309380499
Category : Medical
Languages : en
Pages : 397
Book Description
In an era of promising advances in cancer research, there are considerable and even alarming gaps in the fundamental knowledge and understanding of ovarian cancer. Researchers now know that ovarian cancer is not a single disease-several distinct subtypes exist with different origins, risk factors, genetic mutations, biological behaviors, and prognoses. However, persistent questions have impeded progress toward improving the prevention, early detection, treatment, and management of ovarian cancers. Failure to significantly improve morbidity and mortality during the past several decades is likely due to several factors, including the lack of research being performed by specific disease subtype, lack of definitive knowledge of the cell of origin and disease progression, and incomplete understanding of genetic and non-genetic risk factors. Ovarian Cancers examines the state of the science in ovarian cancer research, identifies key gaps in the evidence base and the challenges to addressing those gaps, considers opportunities for advancing ovarian cancer research, and examines avenues for translation and dissemination of new findings and communication of new information to patients and others. This study makes recommendations for public- and private-sector efforts that could facilitate progress in reducing the incidence of morbidity and mortality from ovarian cancers.
Publisher: National Academies Press
ISBN: 0309380499
Category : Medical
Languages : en
Pages : 397
Book Description
In an era of promising advances in cancer research, there are considerable and even alarming gaps in the fundamental knowledge and understanding of ovarian cancer. Researchers now know that ovarian cancer is not a single disease-several distinct subtypes exist with different origins, risk factors, genetic mutations, biological behaviors, and prognoses. However, persistent questions have impeded progress toward improving the prevention, early detection, treatment, and management of ovarian cancers. Failure to significantly improve morbidity and mortality during the past several decades is likely due to several factors, including the lack of research being performed by specific disease subtype, lack of definitive knowledge of the cell of origin and disease progression, and incomplete understanding of genetic and non-genetic risk factors. Ovarian Cancers examines the state of the science in ovarian cancer research, identifies key gaps in the evidence base and the challenges to addressing those gaps, considers opportunities for advancing ovarian cancer research, and examines avenues for translation and dissemination of new findings and communication of new information to patients and others. This study makes recommendations for public- and private-sector efforts that could facilitate progress in reducing the incidence of morbidity and mortality from ovarian cancers.
Canadian Cancer Statistics
What You Need to Know about Prostate Cancer
Canadian Immunization Guide
Author: Canada. Comité consultatif national de l'immunisation
Publisher:
ISBN: 9780660193922
Category : Immunization
Languages : en
Pages : 392
Book Description
The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization.
Publisher:
ISBN: 9780660193922
Category : Immunization
Languages : en
Pages : 392
Book Description
The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization.
Area Socioeconomic Variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975-1999
Answers to Your Questions about Cancer
Socioeconomic Inequalities in Health
Author: Nanak Kakwani
Publisher:
ISBN:
Category : Medical care
Languages : en
Pages : 36
Book Description
Publisher:
ISBN:
Category : Medical care
Languages : en
Pages : 36
Book Description
The Cancer Olympics
Author: Robin McGee
Publisher: FriesenPress
ISBN: 1460229142
Category : Biography & Autobiography
Languages : en
Pages : 370
Book Description
National Indie Excellence Award Finalist (2016) for Cancer. Pinnacle Book Achievement Award Winner (2016) for Best Inspirational. Feathered Quill Book Awards Silver Medal for Best Inspirational (2016). Book Excellence Award Finalist (2016) for Inspiration. International Book Award Finalist (2015) for Health-Cancer. Readers' Favorite Award Finalist (2015) for Grief-Hardship. USA Best Book Award Finalist (2015) for Health-Cancer. Listed in The 55 Best Self-Published Books of 2015 - Kirkus IndieReader. Diagnosed with a late-stage cancer, after years of bungled and inadequate medical attention...and then to discover that the best-practice chemotherapy is not available in your province. After her delayed diagnosis of colorectal cancer, Robin McGee reaches out to her community using a blog entitled "Robin's Cancer Olympics." Often uplifting and humourous, the blog posts and responses follow her into the harsh landscape of cancer treatment, medical regulation, and provincial politics. If she and her supporters are to be successful in lobbying the government for the chemotherapy, she must overcome many formidable and frightening hurdles. And time is running out. . . A true story, The Cancer Olympics is a suspenseful and poignant treatment of an unthinkable situation, an account of advocacy and survival that explores our deepest values regarding democracy, medicine, and friendship. Half of the proceeds from the sale of this book go to the Canadian Cancer Society and the Colorectal Cancer Association of Canada....
Publisher: FriesenPress
ISBN: 1460229142
Category : Biography & Autobiography
Languages : en
Pages : 370
Book Description
National Indie Excellence Award Finalist (2016) for Cancer. Pinnacle Book Achievement Award Winner (2016) for Best Inspirational. Feathered Quill Book Awards Silver Medal for Best Inspirational (2016). Book Excellence Award Finalist (2016) for Inspiration. International Book Award Finalist (2015) for Health-Cancer. Readers' Favorite Award Finalist (2015) for Grief-Hardship. USA Best Book Award Finalist (2015) for Health-Cancer. Listed in The 55 Best Self-Published Books of 2015 - Kirkus IndieReader. Diagnosed with a late-stage cancer, after years of bungled and inadequate medical attention...and then to discover that the best-practice chemotherapy is not available in your province. After her delayed diagnosis of colorectal cancer, Robin McGee reaches out to her community using a blog entitled "Robin's Cancer Olympics." Often uplifting and humourous, the blog posts and responses follow her into the harsh landscape of cancer treatment, medical regulation, and provincial politics. If she and her supporters are to be successful in lobbying the government for the chemotherapy, she must overcome many formidable and frightening hurdles. And time is running out. . . A true story, The Cancer Olympics is a suspenseful and poignant treatment of an unthinkable situation, an account of advocacy and survival that explores our deepest values regarding democracy, medicine, and friendship. Half of the proceeds from the sale of this book go to the Canadian Cancer Society and the Colorectal Cancer Association of Canada....
Preoperative (Neoadjuvant) Chemotherapy
Author: Joseph Ragaz
Publisher: Springer Science & Business Media
ISBN: 3642826717
Category : Medical
Languages : en
Pages : 172
Book Description
Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations of many aspects of the present management of cancer will have to follow. Therefore, before such therapy can be fully and routinely implemented, results of the novel treatment and its rationale have to be carefully evaluated. In preoperative treatment, other features will likely gain impor tance. For the first time, clinicians have a chance to follow the in vivo response of the tumor exposed to preoperative chemotherapy. The subsequent histological assessment of the tumor sample may likely become an important prognostic guide, permitting more re fined individual approaches to the planning of postoperative adju vant treatment. The value of such a treatment strategy can already be appreciated in the clinical setting, as seen from the therapy of osteosarcoma. Furthermore, preoperative chemotherapy might render previously inoperable tumors operable and hence resectable with a curative intention. The preoperative reduction of tumor bulk may also effectively decrease the need for more radical operations, permitting a more uniform adoption of conservative surgery.
Publisher: Springer Science & Business Media
ISBN: 3642826717
Category : Medical
Languages : en
Pages : 172
Book Description
Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations of many aspects of the present management of cancer will have to follow. Therefore, before such therapy can be fully and routinely implemented, results of the novel treatment and its rationale have to be carefully evaluated. In preoperative treatment, other features will likely gain impor tance. For the first time, clinicians have a chance to follow the in vivo response of the tumor exposed to preoperative chemotherapy. The subsequent histological assessment of the tumor sample may likely become an important prognostic guide, permitting more re fined individual approaches to the planning of postoperative adju vant treatment. The value of such a treatment strategy can already be appreciated in the clinical setting, as seen from the therapy of osteosarcoma. Furthermore, preoperative chemotherapy might render previously inoperable tumors operable and hence resectable with a curative intention. The preoperative reduction of tumor bulk may also effectively decrease the need for more radical operations, permitting a more uniform adoption of conservative surgery.